CREB1 and esophageal squamous cell carcinoma: Actually, small molecule inhibitors of CREB1 have been developed,[30, 31, 32, 33, 34] our findings highlight the potential of imperatorin, which directly targets CREB1, as a therapeutic option for the patients with metastatic ESCC.